News

Biopharma Expands Clinical Program of Lead Drug Candidate to Treat Chronic Cough

September 30, 2021 (Investorideas.com Newswire) Algernon Pharmaceuticals will now pursue Ifenprodil in chronic cough based on encouraging recent study results in a Phase 2 trial.

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

Leave a reply

Your email address will not be published. Required fields are marked *

More in:News

Next Article:

0 %